Life Sciences, Medicine & Pharma

India's Life Sciences, Medicine, and Pharma sector is a major global player, known particularly for being the world's largest supplier of generic drugs and for its role in producing affordable medicines and vaccines. It is ranked third worldwide in volume. The industry has grown significantly, driven by expertise in manufacturing, a large skilled workforce, and innovation in areas like vaccine development and novel drug delivery systems. Facilities of some of the major Indian pharma companies have received approvals from regulatory bodies like the USFDA.

India is also a leading destination for medical tourism, attracting international patients seeking high-quality and affordable medical treatments in areas like cardiology, orthopedics, and fertility care. Key factors contributing to its popularity include lower costs compared to Western countries, a high standard of care from English-speaking doctors, and the availability of modern technology. The government actively promotes this sector through initiatives like the "Heal in India" program and specialized e-visas to simplify the travel process for foreign nationals.

Key characteristics of the industry

• Global leadership in generics: India is the largest supplier of generic drugs globally, providing 20% of the world's generic medicines by volume and 40% of the generic drug demand in the U.S.
• Biotechnology: The sector is seeing increased activity, with companies focusing on novel drug delivery systems, new molecules, and materials. Funding is also expanding for India's emerging biotech sector.
• Vaccines: India is a major vaccine producer, with manufacturers contributing 40% of the World Health Organization (WHO) prequalified vaccines. The industry has gained international attention for its vaccine manufacturing capabilities, including its indigenous COVID-19 vaccine, Covaxin.
• Medical Devices: The market includes a wide range of products, from hospital furniture to high-end imaging devices. Companies like Vikrant Life Sciences are significant players in the manufacturing and distribution of medical devices.
• Skilled workforce and manufacturing expertise: India has a large pool of skilled professionals and a strong foundation in process development and manufacturing, which has been crucial to its growth.
• Innovation and R&D: While historically strong in generics, the industry is increasingly focusing on research and development, including creating new molecules, novel drug delivery systems, and biosimilars.
• Regulatory landscape: The presence of numerous USFDA-approved manufacturing facilities underscores the industry's commitment to quality and its integration into the global supply chain.

Growth drivers and outlook

• Increasing demand: Driven by both domestic and foreign demand, the Indian pharmaceutical industry is projected to reach US$150 billion in the next decade.
• Favorable regulatory changes: Drastically reduced approval times for new facilities have made India a more attractive destination for life science and pharmaceutical investment.
• Scientific advancements: India is leveraging scientific progress, augmented intelligence, and digital data to transform traditional healthcare models and enhance patient experience.
• Government initiatives: Measures such as the Production Linked Incentive (PLI) scheme have been implemented to boost domestic manufacturing of key pharmaceutical ingredients.

Future trends

• Digital health: Integration of digital data and AI is becoming crucial for life science organizations to provide personalized experiences and enhance patient care.
• Focus on wellness: Heightened consumer awareness following the COVID-19 pandemic has fueled a surge of entrepreneurial activity in health-related fields, such as nutraceuticals and cosmeceuticals.

Across the whole Pharmaceutical and Life Sciences value chain, Millennial India International Chamber of Commerce has been highly active in Healthcare sector to take initiatives to promote Health Sector in the country. MIICCIA has been working towards providing a platform for both private and government to mutually discuss upon various issues of delivering health care in India, through conferences, exhibitions and interactive sessions. By connecting private sector players from Hospitals, Insurance with policy makers, regulatory bodies, subject experts in MIICCIA is taking forward the Universal Health Coverage agenda.